These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 33210835)
1. Neuroretinal dysfunction revealed by a flicker electroretinogram correlated with peripheral nerve dysfunction and parameters of atherosclerosis in patients with diabetes. Kawai M; Himeno T; Shibata Y; Hirai N; Asada-Yamada Y; Asano-Hayami E; Ejima Y; Kasagi R; Nagao E; Sugiura-Roth Y; Nakai-Shimoda H; Nakayama T; Yamada Y; Ishikawa T; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Nakamura J; Kamiya H J Diabetes Investig; 2021 Jul; 12(7):1236-1243. PubMed ID: 33210835 [TBL] [Abstract][Full Text] [Related]
2. Nerve conduction velocity is negatively associated with intima-media thickness and brachial-ankle pulse wave velocity in men with type 2 diabetes mellitus. Tanaka S; Kanazawa I; Sugimoto T PLoS One; 2018; 13(12):e0209503. PubMed ID: 30571795 [TBL] [Abstract][Full Text] [Related]
3. Point-of-care nerve conduction device predicts the severity of diabetic polyneuropathy: A quantitative, but easy-to-use, prediction model. Kamiya H; Shibata Y; Himeno T; Tani H; Nakayama T; Murotani K; Hirai N; Kawai M; Asada-Yamada Y; Asano-Hayami E; Nakai-Shimoda H; Yamada Y; Ishikawa T; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Baba M; Nakamura J J Diabetes Investig; 2021 Apr; 12(4):583-591. PubMed ID: 32799422 [TBL] [Abstract][Full Text] [Related]
4. Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy. Hayashi Y; Himeno T; Shibata Y; Hirai N; Asada-Yamada Y; Sasajima S; Asano-Hayami E; Motegi M; Asano S; Kato M; Nakai-Shimoda H; Tani H; Miura-Yura E; Morishita Y; Kondo M; Tsunekawa S; Nakayama T; Nakamura J; Kamiya H J Diabetes Investig; 2024 Jun; 15(6):736-742. PubMed ID: 38421109 [TBL] [Abstract][Full Text] [Related]
5. Alterations of retinal thickness measured by optical coherence tomography correlate with neurophysiological measures in diabetic polyneuropathy. Yamada Y; Himeno T; Tsuboi K; Shibata Y; Kawai M; Asada-Yamada Y; Hayashi Y; Asano-Hayami E; Hayami T; Ishida Y; Ejima Y; Motegi M; Asano S; Kato M; Nagao E; Nakai-Shimoda H; Ishikawa T; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Nakayama T; Kamei M; Nakamura J; Kamiya H J Diabetes Investig; 2021 Aug; 12(8):1430-1441. PubMed ID: 33300294 [TBL] [Abstract][Full Text] [Related]
6. Factors associated with peripheral neuropathy in type 2 diabetes: Subclinical versus confirmed neuropathy. Unmar Y; Zafar MI; Gao F J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):337-342. PubMed ID: 28585130 [TBL] [Abstract][Full Text] [Related]
7. Assessment of diabetic neuropathy using a point-of-care nerve conduction device shows significant associations with the LDIFLARE method and clinical neuropathy scoring. Sharma S; Vas PR; Rayman G J Diabetes Sci Technol; 2015 Jan; 9(1):123-31. PubMed ID: 25231114 [TBL] [Abstract][Full Text] [Related]
8. Correlation of Baba's diabetic neuropathy classification with various diabetes-related complications. Iwamoto Y; Nakanishi S; Itoh T; Nakao E; Sugisaki T; Kusano T; Ohnishi M; Takenouchi H; Iwamoto H; Sanada J; Fushimi Y; Katakura Y; Hemmi S; Kimura T; Tatsumi F; Shimoda M; Mune T; Kaku K; Kaneto H Front Endocrinol (Lausanne); 2022; 13():1054934. PubMed ID: 36387868 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the severity of diabetic polyneuropathy aids in predicting the risk of developing diabetic complications in patients with untreated diabetes. Horinouchi S; Deguchi T; Mukai M; Ijuin A; Kawamoto Y; Nishio Y Front Endocrinol (Lausanne); 2024; 15():1380970. PubMed ID: 38559690 [TBL] [Abstract][Full Text] [Related]
10. Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus. Picconi F; Mataluni G; Ziccardi L; Parravano M; Di Renzo A; Ylli D; Pasqualetti P; Studer V; Chioma L; Marfia GA; Frontoni S J Diabetes Res; 2018; 2018():9763507. PubMed ID: 30402503 [TBL] [Abstract][Full Text] [Related]
11. Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study. Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO Cardiovasc Diabetol; 2015 Oct; 14():140. PubMed ID: 26466574 [TBL] [Abstract][Full Text] [Related]
12. Association of left ventricular myocardial dysfunction with diabetic polyneuropathy. Tabako S; Harada M; Sugiyama K; Ohara H; Ikeda T J Med Ultrason (2001); 2019 Jan; 46(1):69-79. PubMed ID: 30155803 [TBL] [Abstract][Full Text] [Related]
13. Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device. Zeng Y; Cao D; Yang D; Zhuang X; Yu H; Hu Y; Zhang Y; Yang C; He M; Zhang L Doc Ophthalmol; 2020 Jun; 140(3):211-220. PubMed ID: 31720980 [TBL] [Abstract][Full Text] [Related]
15. Association between brachial-ankle pulse wave velocity and microvascular complications in type 2 diabetes mellitus. Pei Y; Shu Y; Deng B; Liu Y BMC Endocr Disord; 2023 May; 23(1):98. PubMed ID: 37143027 [TBL] [Abstract][Full Text] [Related]
16. Bilirubin is inversely related to diabetic peripheral neuropathy assessed by sural nerve conduction study. Abe K; Maeda Y; Matsuzaki C; Yokomizo H; Inoue T; Sonoda N; Ogawa Y; Inoguchi T J Diabetes Investig; 2021 Nov; 12(11):2028-2035. PubMed ID: 33949141 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D and diabetic peripheral neuropathy: A multi-centre nerve conduction study among Chinese patients with type 2 diabetes. Pang C; Yu H; Cai Y; Song M; Feng F; Gao L; Li K; Chen Y; Xie J; Cheng Y; Lin E; Pan X; Zhang W; Deng B Diabetes Metab Res Rev; 2023 Oct; 39(7):e3679. PubMed ID: 37337761 [TBL] [Abstract][Full Text] [Related]
18. Corneal confocal microscopy predicts 4-year incident peripheral neuropathy in type 1 diabetes. Pritchard N; Edwards K; Russell AW; Perkins BA; Malik RA; Efron N Diabetes Care; 2015 Apr; 38(4):671-5. PubMed ID: 25573881 [TBL] [Abstract][Full Text] [Related]
19. Role of a mydriasis-free, full-field flicker ERG device in the detection of diabetic retinopathy. Değirmenci MFK; Demirel S; Batıoğlu F; Özmert E Doc Ophthalmol; 2018 Dec; 137(3):131-141. PubMed ID: 30334119 [TBL] [Abstract][Full Text] [Related]
20. Quantitative vibration perception threshold in assessing diabetic polyneuropathy: Should the cut-off value be adjusted for Chinese individuals with type 2 diabetes? Liu M; Gao Y; Chen DW; Lin S; Wang C; Chen LH; Ran XW J Diabetes Investig; 2021 Sep; 12(9):1663-1670. PubMed ID: 33512757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]